Archive: 10/11/2014

Researchers find new target for kidney cancer therapy

Cincinnati Cancer Center (CCC) researchers have discovered that a membrane channel, Transient Receptor Potential Melastatin 3, or TRPM3, promotes growth of kidney cancer tumors, and targeting this channel therapeutically ...

page 4 from 11